Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.12 -0.01 (-0.24%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Change in Accured Expenses (2017 - 2026)

Updated

Adial Pharmaceuticals (ADIL) posted Change in Accured Expenses of -$2.55 million for Q2 2026, compared with -$218,239 a year earlier.

Analysis

Adial Pharmaceuticals (ADIL) Change in Accured Expenses (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Adial Pharmaceuticals was -$1.81 million; for FY2025, it was $405,077, up 102.8% from FY2024.

  • Annual Change in Accured Expenses shows a five-year compound annual growth rate of -2.4% (FY2020 to FY2025).
  • In prior years, Adial Pharmaceuticals' Change in Accured Expenses was $199,709 in FY2024, -$485,580 in FY2023, -$1.41 million in FY2022 and $1.52 million in FY2021 (+231.6%).
  • The Q2 2026 figure stands as the lowest quarterly Change in Accured Expenses in data going back to Q3 2017.
  • On a year-over-year basis, Change in Accured Expenses increased in four of the last five quarters, with growth averaging 100.5%.
  • The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q4 2024, with growth of 155.3%; the weakest was Q3 2021, with a decline of 94.2%.
  • According to Business Quant data, Change in Accured Expenses for the three prior quarters was $194,802 (Q1 2026), $448,011 (Q4 2025) and $94,066 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Adial Pharmaceuticals 19.04 Mn 19.04 Mn - -2.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.55 Mn
Mar 31, 2026 194,802.00
Dec 31, 2025 448,011.00
Sep 30, 2025 94,066.00
Jun 30, 2025 -218,239.00
Mar 31, 2025 81,239.00
Dec 31, 2024 176,528.00
Sep 30, 2024 165,772.00
Jun 30, 2024 -40,107.00
Mar 31, 2024 -102,484.00
Dec 31, 2023 69,133.00
Sep 30, 2023 84,203.00
Jun 30, 2023 -822,637.00
Mar 31, 2023 183,721.00
Dec 31, 2022 110,082.00
Sep 30, 2022 -66,608.00
Jun 30, 2022 -774,978.00
Mar 31, 2022 -682,099.00
Dec 31, 2021 652,091.00
Sep 30, 2021 35,115.00
API Access

Adial Pharmaceuticals Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ADIL&period=max&api_key=YOUR_API_KEY